To purchase hard copies of this book, please email:
orders@intechopen.com
Share this page
This book is indexed in
Medicine » Mental and Behavioural Disorders and Diseases of the Nervous System
Alzheimer's Disease Pathogenesis-Core Concepts, Shifting Paradigms and Therapeutic Targets
Edited by Suzanne De La Monte, ISBN 978-953-307-690-4, Hard cover, 686 pages, Publisher: InTech, Chapters published September 12, 2011 under CC BY-NC-SA 3.0 license
DOI: 10.5772/951
Alzheimer's Disease Pathogenesis: Core Concepts, Shifting Paradigms, and Therapeutic Targets, delivers the concepts embodied within its title. This exciting book presents the full array of theories about the causes of Alzheimer's, including fresh concepts that have gained ground among both professionals and the lay public. Acknowledged experts provide highly informative yet critical reviews of the factors that most likely contribute to Alzheimer's, including genetics, metabolic deficiencies, oxidative stress, and possibly environmental exposures. Evidence that Alzheimer's resembles a brain form of diabetes is discussed from different perspectives, ranging from disease mechanisms to therapeutics. This book is further energized by discussions of how neurotransmitter deficits, neuro-inflammation, and oxidative stress impair neuronal plasticity and contribute to Alzheimer's neurodegeneration. The diversity of topics presented in just the right depth will interest clinicians and researchers alike. This book inspires confidence that effective treatments could be developed based upon the expanding list of potential therapeutic targets.
- Chapter 1
Alzheimer ́s Disease – The New Actors of an Old Drama - Chapter 2
Pathophysiology of Late Onset Alzheimer Disease - Chapter 3
Expression and Cerebral Function of Amyloid Precursor Protein After Rat Traumatic Brain Injury - Chapter 4
Key Enzymes and Proteins in Amyloid-Beta Production and Clearance - Chapter 5
Transporters in the Blood-Brain Barrier - Chapter 6
Contribution of Multivesicular Bodies to the Prion-Like Propagation of Lesions in Alzheimer’s Disease - Chapter 7
Pathological Stages of Abnormally Processed Tau Protein During Its Aggregation into Fibrillary Structures in Alzheimer’s Disease - Chapter 8
Structure and Toxicity of the Prefibrillar Aggregation States of Beta Peptides in Alzheimer’s Disease - Chapter 9
Structural and Toxic Properties of Protein Aggregates: Towards a Molecular Understanding of Alzheimer's Disease - Chapter 10
The Role of Glycogen Synthase Kinase-3 (GSK-3) in Alzheimer’s Disease - Chapter 11
Pin1: A New Enzyme Pivotal for Protecting Against Alzheimer’s Disease - Chapter 12
Selectivity of Cell Signaling in the Neuronal Response Based on NGF Mutations and Peptidomimetics in the Treatment of Alzheimers Disease - Chapter 13
Advances in MicroRNAs and Alzheimer’s Disease Research - Chapter 14
Role of Mitochondria in Alzheimer ́s Disease - Chapter 15
Oxidative Stress in Alzheimer’s Disease: Pathogenesis, Biomarkers and Therapy - Chapter 16
Impact of Oxidative - Nitrosative Stress on Cholinergic Presynaptic Function - Chapter 17
Metals Involvement in Alzheimer’s Disease Pathogenesis - Chapter 18
Alzheimer’s Disease and Metal Contamination: Aspects on Genotoxicity - Chapter 19
Glucose Metabolism and Insulin Action in Alzheimer’s Disease Pathogenesis - Chapter 20
Insulin Resistance, Cognitive Impairment and Neurodegeneration: Roles of Nitrosamine Exposure, Diet and Lifestyles - Chapter 21
The Relations Between the Vitamins and Alzheimer Dementia - Chapter 22
Hypotension in Subcortical Vascular Dementia, a New Risk Factor – Wasn’t It Hypertension? - Chapter 23
Autophagy-Derived Alzheimer’s Pathogenesis - Chapter 24
Plasmalogen Deficit: A New and Testable Hypothesis for the Etiology of Alzheimer’s Disease - Chapter 25
Gangliosides as a Double-Edged Swordin Neurodegenerative Disease - Chapter 26
Structure Based 3D-QSAR Studies on Cholinesterase Inhibitors - Chapter 27
Tau Oligomers as Potential Drug Target for Alzheimer Disease (AD) Treatment - Chapter 28
In Silico Design of Preventive Drugs for Alzheimer’s Disease - Chapter 29
Protective Roles of the Incretin Hormones Glucagon-Like Peptide-1 and Glucose-Dependent Insolinotropic Polypeptide Hormones in Neurodegeneration


